-

SHAREHOLDER ALERT: Kaskela Law LLC Investigates Fairness of $9.60 Per Share Buyout Price for Pzena Investment Management, Inc. Shareholders (PZN) and Encourages Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Pzena Investment Management, Inc. (NYSE: PZN) (“Pzena”) on behalf of the company’s investors.

On July 26, 2022, Pzena announced that it would be acquired at a price of $9.60 per share in cash. Following the closing of the proposed transaction, Pzena’s shareholders will be cashed out of their investment position, and the company’s shares will no longer be publicly traded. As recently as February 2022, shares of Pzena’s stock traded above $10.50 per share.

The investigation seeks to determine whether Pzena shareholders will be receiving sufficient monetary consideration for their shares, and whether Pzena’s officers and directors violated the securities laws and/or breached their fiduciary duties in agreeing to sell the Company at $9.60 per share.

Pzena shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/pzena-investment-management/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation, and has helped recover in excess of $150 million on behalf of victimized investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com
Adrienne Bell, Esq.
abell@kaskelalaw.com
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NYSE:PZN

Release Versions

Contacts

D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com
Adrienne Bell, Esq.
abell@kaskelalaw.com
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Select Medical Holdings Shareholder Buyout and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) on behalf of the company’s shareholders to determine whether the recently announced proposed buyout of SEM shareholders is fair and provides investors with sufficient monetary consideration for their shares.Click here for additional information: https://kaskelalaw.com/case/select-medical/On March 2, 2026, Select Medical announced that it had agreed to...

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Global Business Travel Group Inc. Shareholder Buyout and Encourages Investors to Contact the Firm – GBTG

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT”) on behalf of the company’s shareholders to determine whether the recently announced buyout of GBTG shareholders is fair and provides investors with sufficient monetary consideration for their shares. Click here for additional information: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, Amex GBT announced that it had agreed to...

TRADEWEB: Kaskela Law Firm Announces Investigation of Tradeweb Markets Inc. (TW) and Encourages Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Tradeweb Markets Inc. (NASDAQ: TW) (“Tradeweb”) on behalf of the company’s investors. The investigation seeks to determine whether Tradeweb and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Tradeweb shareholders who would like to learn more about the investigation and their legal rights and options are encouraged...
Back to Newsroom